Mara A McAdams-DeMarco1,2, Matthew Daubresse2, Sunjae Bae3, Alden L Gross2,4, Michelle C Carlson4,5, Dorry L Segev3,2. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; mara@jhu.edu. 2. Departments of Epidemiology and. 3. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Johns Hopkins University Center on Aging and Health, Baltimore, Maryland. 5. Mental Health, Bloomberg School of Public Health, Baltimore, Maryland; and.
Abstract
BACKGROUND AND OBJECTIVES: Older patients with ESKD experience rapid declines in executive function after initiating hemodialysis; these impairments might lead to high rates of dementia and Alzheimer's disease in this population. We estimated incidence, risk factors, and sequelae of diagnosis with dementia and Alzheimer's disease among older patients with ESKD initiating hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied 356,668 older (age ≥66 years old) patients on hemodialysis (January 1, 2001 to December 31, 2013) from national registry data (US Renal Data System) linked to Medicare. We estimated the risk (cumulative incidence) of diagnosis of dementia and Alzheimer's disease and studied factors associated with these disorders using competing risks models to account for death, change in dialysis modality, and kidney transplant. We estimated the risk of subsequent mortality using Cox proportional hazards models. RESULTS: The 1- and 5-year risks of diagnosed dementia accounting for competing risks were 4.6% and 16% for women, respectively, and 3.7% and 13% for men, respectively. The corresponding Alzheimer's disease diagnosis risks were 0.6% and 2.6% for women, respectively, and 0.4% and 2.0% for men, respectively. The strongest independent risk factors for diagnosis of dementia and Alzheimer's disease were age ≥86 years old (dementia: hazard ratio, 2.11; 95% confidence interval, 2.04 to 2.18; Alzheimer's disease: hazard ratio, 2.11; 95% confidence interval, 1.97 to 2.25), black race (dementia: hazard ratio, 1.70; 95% confidence interval, 1.67 to 1.73; Alzheimer's disease: hazard ratio, 1.78; 95% confidence interval, 1.71 to 1.85), women (dementia: hazard ratio, 1.10; 95% confidence interval, 1.08 to 1.12; Alzheimer's disease: hazard ratio, 1.12; 95% confidence interval, 1.08 to 1.16), and institutionalization (dementia: hazard ratio, 1.36; 95% confidence interval, 1.33 to 1.39; Alzheimer's disease: hazard ratio, 1.10; 95% confidence interval, 1.05 to 1.15). Older patients on hemodialysis with a diagnosis of dementia were at 2.14-fold (95% confidence interval, 2.07 to 2.22) higher risk of subsequent mortality; those with a diagnosis of Alzheimer's disease were at 2.01-fold (95% confidence interval, 1.89 to 2.15) higher mortality risk. CONCLUSIONS: Older patients on hemodialysis are at substantial risk of diagnosis with dementia and Alzheimer's disease, and carrying these diagnoses is associated with a twofold higher mortality.
BACKGROUND AND OBJECTIVES: Older patients with ESKD experience rapid declines in executive function after initiating hemodialysis; these impairments might lead to high rates of dementia and Alzheimer's disease in this population. We estimated incidence, risk factors, and sequelae of diagnosis with dementia and Alzheimer's disease among older patients with ESKD initiating hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied 356,668 older (age ≥66 years old) patients on hemodialysis (January 1, 2001 to December 31, 2013) from national registry data (US Renal Data System) linked to Medicare. We estimated the risk (cumulative incidence) of diagnosis of dementia and Alzheimer's disease and studied factors associated with these disorders using competing risks models to account for death, change in dialysis modality, and kidney transplant. We estimated the risk of subsequent mortality using Cox proportional hazards models. RESULTS: The 1- and 5-year risks of diagnosed dementia accounting for competing risks were 4.6% and 16% for women, respectively, and 3.7% and 13% for men, respectively. The corresponding Alzheimer's disease diagnosis risks were 0.6% and 2.6% for women, respectively, and 0.4% and 2.0% for men, respectively. The strongest independent risk factors for diagnosis of dementia and Alzheimer's disease were age ≥86 years old (dementia: hazard ratio, 2.11; 95% confidence interval, 2.04 to 2.18; Alzheimer's disease: hazard ratio, 2.11; 95% confidence interval, 1.97 to 2.25), black race (dementia: hazard ratio, 1.70; 95% confidence interval, 1.67 to 1.73; Alzheimer's disease: hazard ratio, 1.78; 95% confidence interval, 1.71 to 1.85), women (dementia: hazard ratio, 1.10; 95% confidence interval, 1.08 to 1.12; Alzheimer's disease: hazard ratio, 1.12; 95% confidence interval, 1.08 to 1.16), and institutionalization (dementia: hazard ratio, 1.36; 95% confidence interval, 1.33 to 1.39; Alzheimer's disease: hazard ratio, 1.10; 95% confidence interval, 1.05 to 1.15). Older patients on hemodialysis with a diagnosis of dementia were at 2.14-fold (95% confidence interval, 2.07 to 2.22) higher risk of subsequent mortality; those with a diagnosis of Alzheimer's disease were at 2.01-fold (95% confidence interval, 1.89 to 2.15) higher mortality risk. CONCLUSIONS: Older patients on hemodialysis are at substantial risk of diagnosis with dementia and Alzheimer's disease, and carrying these diagnoses is associated with a twofold higher mortality.
Authors: Emma O'Lone; Michael Connors; Philip Masson; Sunny Wu; Patrick J Kelly; David Gillespie; Daniel Parker; William Whiteley; Giovanni F M Strippoli; Suetonia C Palmer; Jonathan C Craig; Angela C Webster Journal: Am J Kidney Dis Date: 2016-02-23 Impact factor: 8.860
Authors: Mara A McAdams-DeMarco; Sunjae Bae; Nadia Chu; Alden L Gross; Charles H Brown; Esther Oh; Paul Rosenberg; Karin J Neufeld; Ravi Varadhan; Marilyn Albert; Jeremy Walston; Dorry L Segev Journal: J Am Soc Nephrol Date: 2016-12-15 Impact factor: 10.121
Authors: Orrin B Myers; Christopher Adams; Mark R Rohrscheib; Karen S Servilla; Dana Miskulin; Edward J Bedrick; Philip G Zager Journal: J Am Soc Nephrol Date: 2010-10-14 Impact factor: 10.121
Authors: Fabienne Dobbels; Melissa A Skeans; Jon J Snyder; Anne V Tuomari; J Ross Maclean; Bertram L Kasiske Journal: Am J Kidney Dis Date: 2008-03-20 Impact factor: 8.860
Authors: Nadia M Chu; Zhan Shi; Christine E Haugen; Silas P Norman; Alden L Gross; Daniel C Brennan; Michelle C Carlson; Dorry L Segev; Mara A McAdams-DeMarco Journal: Am J Kidney Dis Date: 2020-02-03 Impact factor: 8.860
Authors: Nadia M Chu; Xiaomeng Chen; Silas P Norman; Jessica Fitzpatrick; Stephen M Sozio; Bernard G Jaar; Alena Frey; Michelle M Estrella; Qian-Li Xue; Rulan S Parekh; Dorry L Segev; Mara A McAdams-DeMarco Journal: Am J Nephrol Date: 2020-07-08 Impact factor: 3.754
Authors: Aarti Mathur; JiYoon B Ahn; Whitney Sutton; Martha A Zeiger; Dorry L Segev; Mara McAdams-DeMarco Journal: Surgery Date: 2022-03-21 Impact factor: 4.348
Authors: Nadia M Chu; Xiaomeng Chen; Sunjae Bae; Daniel C Brennan; Dorry L Segev; Mara A McAdams-DeMarco Journal: Transplantation Date: 2021-09-01 Impact factor: 5.385
Authors: Nadia M Chu; Xiaomeng Chen; Alden L Gross; Michelle C Carlson; Jacqueline M Garonzik-Wang; Silas P Norman; Aarti Mathur; Maheen Z Abidi; Daniel C Brennan; Dorry L Segev; Mara A McAdams-DeMarco Journal: Clin Transplant Date: 2021-08-03 Impact factor: 3.456